Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis
Objective To examine the prevalence of side effects with methotrexate (MTX) and tumor necrosis factor inhibitors (TNFi) among patients with psoriatic arthritis (PsA) and rheumatoid arthritis (RA). Methods This retrospective analysis, conducted between January 2000 and January 2019, used data from th...
Main Authors: | Alexis Ogdie, Ervant J. Maksabedian Hernandez, Yomei Shaw, Bradley Stolshek, Kaleb Michaud |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-11-01
|
Series: | ACR Open Rheumatology |
Online Access: | https://doi.org/10.1002/acr2.11467 |
Similar Items
-
Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study
by: Alexis Ogdie, et al.
Published: (2023-04-01) -
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study
by: Ulf Lindström, et al.
Published: (2023-05-01) -
Methotrexate in psoriasis and psoriatic arthritis
by: Coates, L, et al.
Published: (2020) -
Psoriatic arthritis: prospects for the future
by: Simon Hackett, et al.
Published: (2022-03-01) -
Methotrexate in a psoriatic arthritis patient
by: K. V. Aleksanyan, et al.
Published: (2022-12-01)